Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Verastem Inc VSTM

Healthcare Biotechnology
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration... see more

Current News (NDAQ:VSTM)

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference

Business Wire November 25, 2025

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire November 14, 2025

Verastem Oncology Announces Proposed Public Offering of Common Stock

Business Wire November 13, 2025

Verastem Oncology to Present at Upcoming Investor Conferences

Business Wire November 5, 2025

Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Business Wire November 4, 2025

Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors

Business Wire October 23, 2025

Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025

Business Wire October 23, 2025

Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics' Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma

Business Wire October 19, 2025

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 7, 2025
View More News ››

Opinion & Analysis (NDAQ:VSTM)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:VSTM)

This stock is for a buy and hold position.

It is not meant for day trading purposes.Thank you.
coolfooldumbguy - January 2, 2025

Using technical analysis for stock.

It's a buy for me this morning at $5.05 cents per share and it's looks good for us shareholders.This one is for a hold,so that it...
coolfooldumbguy - January 2, 2025

WOW Using technical analysis for this stock.

You guys should have been buying this one this morning and you guys would have been watching this one take off and you guys could have...
coolfooldumbguy - December 31, 2024

Verastem (NASDAQ:VSTM) Poised for Breakthrough in Oncology P

http://beyondspx.com/2024/08/01/verastem-nasdaqvstm-poised-for-breakthrough-in-oncology-pipeline/
MikeTester - August 1, 2024

RE:VSTM ..... pays yo money and yo takes

I failed to mention....lots of stock O/S
Iseneschal - May 26, 2023

VSTM ..... pays yo money and yo takes

yo chances Beating my expectations lotsa cash in the Kitty but lots of debt and no Rev...go figure
Iseneschal - May 26, 2023
View more Bullboard ››

Eshbal Functional Food Inc

Eshbal Functional Food Inc

Eshbal Functional Food Inc. researches, develops, and manufactures food products and dietary supplements Israel, North ...
View More »